News Author: Erilyn Riley Publish date: October 6, 2016
NEW YORK—We are “finally” making progress in the treatment of acute myeloid leukemia (AML), according to a speaker at the NCCN 11th Annual Congress: H...
News Author: Erilyn Riley Publish date: October 6, 2016
Photo by D.
News Author: Erilyn Riley Publish date: June 10, 2016
CHICAGO—A phase 3 study of tandem autologous stem cell transplant (ASCT) for children with high-risk neuroblastoma has shown that tandem transpl...
News Author: Erilyn Riley Publish date: June 9, 2016
CHICAGO—Investigators are pursuing the combination of the selective BCL-2 inhibitor venetoclax plus low-dose cytarabine (LDAC) in older, treatme...
News Author: Erilyn Riley Publish date: June 8, 2016
© ASCO/Matt Herp
CHICAGO—The first interim analysis of rituximab plus chemotherapy in children and adolescents with high-risk B-cell non-Hodgkin ly...
News Author: Erilyn Riley Publish date: June 7, 2016
CHICAGO—The addition of the monoclonal antibody daratumumab to bortezomib and dexamethasone, the current standard of care for relapsed/refractory mult...
News Author: Erilyn Riley Publish date: May 19, 2016
Photo by Chad McNeeley
CHICAGO—An interim analysis of a large, phase 3 study has confirmed that upfront autologous stem cell transplantation (ASCT)...
News Author: Erilyn Riley Publish date: May 3, 2016
A new study suggests the composition of a cancer patient’s intestinal microbiome before treatment may predict his risk of developing a bloodstream inf...
News Author: Erilyn Riley Publish date: May 3, 2016
Image courtesy of PNAS
The primary method used to test compounds for anticancer activity in vitro may produce inaccurate results, according to rese...
News Author: Erilyn Riley Publish date: December 30, 2015
Photo by Peter Griffin
ORLANDO, FL—Frailty after hematopoietic stem cell transplant (HSCT), while associated with higher mortality, is not necessar...
News Author: Erilyn Riley Publish date: December 21, 2015
ASH Annual Meeting
Photo courtesy of ASH
ORLANDO, FL—ABL001, an allosteric inhibitor of BCR-ABL1, has shown early evidence of single-agent activit...
News Author: Erilyn Riley Publish date: December 18, 2015
Photo courtesy of ASH
ORLANDO, FL—Cases of musculoskeletal pain have been reported after patients stop taking tyrosine kinase inhibitors (TKIs) for...
News Author: Erilyn Riley Publish date: December 17, 2015
Photo courtesy of ASH
ORLANDO, FL—The pivotal phase 2 study of venetoclax monotherapy in patients with relapsed/refractory 17p-deleted chronic lymp...
News Author: Erilyn Riley Publish date: December 16, 2015
Annual Meeting
Photo courtesy of ASH
ORLANDO, FL—Results of a DFCI ALL Consortium trial have shown that adults with acute lymphoblastic leukemia (...
News Author: Erilyn Riley Publish date: December 16, 2015
Photo courtesy of ASH
ORLANDO, FL—Investigators are pursuing an upfront approval for eltrombopag in combination with immunosuppressive therapy for ...
